July 22, 2019
Connecticut's attorney general, one of several state AGs suing generic-drug companies alleging that they fixed prices, is defending the decision to refer in the complaint to an email suggesting Heritage Pharmaceuticals and other firms tried to obstruct a congressional probe into the generic-drug industry.
July 10, 2019
Heritage Pharmaceuticals accused Connecticut's attorney general on Tuesday of including a privileged email in a new generic-drug price-fixing complaint that suggests the company tried to obstruct a congressional investigation.
June 26, 2019
A Pennsylvania federal judge nixed claims Wednesday that McKesson Corp. earned billions of dollars by cooperating with an industry-wide price-fixing conspiracy among generic-drug makers, ruling that a putative class' allegations in the multidistrict litigation are impermissible suppositions.
June 25, 2019
Multibillion-dollar lawsuits targeting major drugmakers emerged with astonishing frequency during the first half of 2019, threatening civil and criminal liability for all manner of alleged wheeling and dealing. Here, Law360 highlights the latest developments and upcoming action in the pharmaceutical world's hottest new cases.
June 24, 2019
Unredacted emails and phone records show Teva Pharmaceuticals, Pfizer Inc. and 18 other major U.S. drug manufacturers conspiring in an industrywide price-fixing scheme to keep the cost of hundreds of generic drugs artificially high, according to a complaint unsealed Monday by the Maryland attorney general's office.
June 07, 2019
The attorneys general of 44 states and Puerto Rico want a Pennsylvania federal judge to make public an unredacted version of their suit accusing major drugmakers of orchestrating a sprawling scheme to fix the price of generics, saying the suit's subject matter was of "paramount public significance."
June 04, 2019
A lawsuit filed in Connecticut last month by 44 state attorneys general accusing drugmakers of a sprawling scheme to fix generic-drug prices was transferred Tuesday to the Pennsylvania federal court overseeing multidistrict litigation over pricing in the industry.
June 03, 2019
Pharmaceutical companies including Actavis, Teva and Mylan have asked a Pennsylvania federal court to dismiss state law claims by 47 state attorneys general against them in multidistrict litigation accusing them of price-fixing generic drugs.
May 16, 2019
United Healthcare and Humana want the Pennsylvania federal court overseeing sprawling multidistrict litigation over generic drug prices to refuse to grant an order that would set aside part of any money the health care companies might win for the main class.
April 12, 2019
A Pennsylvania federal judge on Thursday refused to certify an interlocutory appeal from pharmaceutical company Perrigo on claims related to one drug in sprawling price-fixing multidistrict litigation, noting that even if the company's appeal goes through, it must still face claims related to other medications.